LYSARC

Home > CALYM > LYSARC

Research topics & objectives

Objectives

LYSARC is a scientifically independent non-profit organization focused on lymphoma clinical research. It is the operational structure associated to the research activities of LYSA, the Lymphoma Study Association, a cooperative group, international leader of lymphoma research.

Research topics

  • Conduire des études cliniques, biopathologiques, épidémiologiques et de vie réelle sur le lymphome.
  • Contribuer par ses expertises métiers et scientifiques aux réflexions et/ou décisions stratégiques au niveau des instances scientifiques décisionnelles du LYSA.
  • Contribuer au soutien des autres acteurs de la recherche sur le lymphome, notamment en termes d’accompagnement, de support technique et de formation aux centres investigateurs.
  • Veiller au développement et au bien-être de ses équipes internes.

Keywords

Clinical research, Lymphoma, Phase 1 to 4

Pascal Bilbault Innovation Lymphome
Pascal Bilbault General Manager

Expertise

Clinical research operations in lymphoma from phase 1 to 4 and beyond.

Lymphomes B Diffus à grandes cellules
Platforms & Technical Resources

Platforms (co-operated with LYSA experts)

  • LYSA-P, centralized review of partient tissue sample, digital pathology platform for scanning, analysis and networking of digital microscope slides, automated analysis of nuclear, cytoplasmic or membrane biomarkers, high-throughput analysis on large patient cohorts on TMA (tissue micro array)
  • LYSA-IM, online review of imaging examinations (positron electron or computed tomography): 4,000 images per year
  • LYSA-BIO, collecting, labeling, management of biological samples
  • EARLY, early phase translational and clinical research: phase I/IIa, first-in-man, first-in-lymphoma or first combo studies: 12 phase I and 30 phase II trials

Databases

  • Clinical, biological, pathological and imaging proprietary databases or more than 23,000 patients

Professional softwares and applications

  • Clinical, biological, pathological and imaging proprietary databases or more than 23,000 patients
  • Clinsight (Data management, e-CRF, e-randomization)
  • SAS (Biostatistics)
  • Safety Easy (Pharmacovigilance)
  • Imagys (imaging central review)
  • LYSABANK:management of tissue samples
  • Sciforma (project portfolio management)
  • GFi (CTMS)
  • Android application ClinTrial Refer LYSA trials status and patient enrolment)

Other

The Lymphoma Academy (training)